Starling Oncology, Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Starling Oncology, Inc. stock issued during period, value, conversion of units for the quarter ending 2025-03-31 was $4.11M.
- Starling Oncology, Inc. stock issued during period, value, conversion of units for fiscal 2025 was $4.11M.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2025-12-31 | $4.11M 10-K · filed 2026-03-12 | |
| 2025-03-31 | $4.11M 10-Q · filed 2026-08-06 |